+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Meningococcal disease in the Israel Defense Force: epidemiologic trends and new challenges



Meningococcal disease in the Israel Defense Force: epidemiologic trends and new challenges



Israel Journal of Medical Sciences 31(1): 54-58



To determine recent trends in its epidemiology and the need to reconsider prophylactic interventions, meningococcal disease in the Israel Defense Force (IDF) from 1975 through 1993 was studied. All cases of meningitis or meningococcemia were included. A considerable increase in the number of cases has been observed since 1991, with serogroup C becoming predominant (76% of cases) since then. Serogroup Y was the second most frequent serogroup during this period, while serogroup B, predominant in the civilian population of Israel, was rare. Most cases occurred during the first 6 months of military service. Seasonality was important, with most of the cases occurring between December and March, although a small summer peak was also noted. Since 1992, three small clusters of meningococcal disease were encountered in the IDF, for the first time, with all cases caused by group C meningococci. In one cluster, the emergence of rifampicin resistance resulted in failure of chemoprophylaxis. The rise in group C and Y cases since 1991, and the occurrence of rifampicin resistance, necessitate considering meningococcal vaccines and new antimicrobial agents for prophylaxis.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 032299542

Download citation: RISBibTeXText

PMID: 7836050


Related references

Epidemiologic characteristics of scabies in the Israel Defense Force. International Journal of Dermatology 28(3): 180-182, 1989

Correlating epidemiologic trends with the genotypes causing meningococcal disease, Maryland. Emerging Infectious Diseases 10(3): 451-456, 2004

First recorded outbreaks of meningococcal disease in the Israel defence force: Three clusters due to serogroup C and the emergence of resistance to rifampicin. Infection 22(2): 69-71, 1994

EpiReview: Meningococcal disease in NSW, 1991-2011: trends in relation to meningococcal C vaccination. New South Wales Public Health Bulletin 24(3): 119-124, 2015

Meningococcal disease: the advances and challenges of meningococcal disease prevention. Human Vaccines 7(8): 828-837, 2011

A prospective epidemiologic study of shigellosis in the Israel Defense Forces: implications for the use of shigella vaccines. Israel Journal of Medical Sciences 23(7): 811-815, 1987

Prehospital intubation success rates among Israel Defense Forces providers: epidemiologic analysis and effect on doctrine. Journal of Trauma and Acute Care Surgery 75(2 Suppl 2): S178-S183, 2013

Epidemiologic trends in hiv infection in the greater tel aviv area israel. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Fc628, 1990

Trends in epidemiology of hepatitis in the Israel Defense Forces. Harefuah 138(9): 755-757, 804-805, 2000

Managing health and finance: challenges, outcome, and control in the Israel Defense Forces. Military Medicine 172(11): 1186-1189, 2007

Prevalence of anterior knee pain and pes planus in Israel defense force recruits. Military Medicine 175(11): 855-857, 2010

Acute non b hepatitis in the israel defense forces comparison of some epidemiologic features before and after the usage of preexposure immune serum globulin prophylaxis. Hepatology 7(6): 1330-1332, 1987

Oral health disparities between ranks in a military environment: Israel Defense Force as a model. Military Medicine 168(4): 326-329, 2003